Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amerise Biosciences Ltd held its 40th Annual General Meeting on 23rd September 2025 at its registered office in Ahmedabad, lasting 35 minutes (3:00 PM to 3:35 PM). Six resolutions were put to shareholders, all of which were passed. These included routine items like approval of FY25 audited financial statements, re-appointment of Director Mr. Dineshkumar Rathod (who retires by rotation), and re-appointment of the statutory auditor. The company also appointed Mr. Kelash Bunkar as a new Independent Director. Additionally, two special resolutions were passed: one to increase the company's borrowing limit under Section 180(1)(c), and another to enable investments, loans and guarantees exceeding limits specified under Section 186 of the Companies Act. Detailed voting results will be filed separately with the stock exchange.
For shareholders, the key takeaways are the appointment of a new Independent Director and management's ability to raise more debt and extend loans/investments — indicating the company may be gearing up for higher financial activity or expansion. The actual market impact depends on the size of these enhanced limits and how management uses them going forward.